-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brigatinib in Vestibular Schwannoma (Acoustic Neuroma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brigatinib in Vestibular Schwannoma (Acoustic Neuroma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brigatinib in Vestibular Schwannoma (Acoustic Neuroma) Drug Details: Brigatinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selumetinib Sulfate in Vestibular Schwannoma (Acoustic Neuroma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selumetinib Sulfate in Vestibular Schwannoma (Acoustic Neuroma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selumetinib Sulfate in Vestibular Schwannoma (Acoustic Neuroma) Drug...
-
Product Insights
NewVestibular Schwannoma (Acoustic Neuroma) – Drugs In Development, 2024
Empower your strategies with our Vestibular Schwannoma (Acoustic Neuroma) – Drugs In Development, 2024 report and make more profitable business decisions. Vestibular schwannoma is a benign, slow-growing tumor that develops from the balance and hearing nerves. It is also called an acoustic neuroma/neurinoma/neurilemma and is mainly caused by overproduction of Schwann cells. It affects the hearing and balance nerves, causing unilateral or asymmetric hearing loss, tinnitus, and dizziness/loss of balance. It can be diagnosed by thorough ear examination and hearing and...
-
Product Insights
NewSeno Medical Instruments Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Seno Medical Instruments Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Seno Medical Instruments Inc (Seno Medical) is a medical device company that manufactures and develops medical imaging devices for cancer screening and diagnostics. The company offers opto-acoustic imaging, a technology that combines optics and acoustics to improve accuracy of cancer diagnosis and Imagio an opto-acoustic breast imaging system to provide physicians with vital information. Its products are used...
-
Product Insights
NewSoliton Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Soliton Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Soliton Inc (Soliton) is a medical device company. It is engaged in developing and commercializing aesthetic devices. The company is developing Rapid Acoustic Pulse (RAP) device which is used for removal of tattoos. It develops technology in partnership with GE and Sanmina. The company is developing acoustic devices for the treatment of cellulite and other indications. The company's products technology...
-
Product Insights
NewAenitis Technologies Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Aenitis Technologies Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Aenitis Technologies develops novel solutions for separation, handling and filtration of biological particles in suspension by using acoustic radiation forces. The company uses its patented acoustophoresis based approach that is applied to micro-scales for cells sorting. Aenitis Technologies develops a technology that utilizes the acoustic strength generated between the walls of a micro-channel in order to separate particles or cells....
-
Product Insights
NewSANUWAVE Health Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our SANUWAVE Health Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company. It develops and commercializes noninvasive biological response activating devices. The company's products portfolio include dermapace, which is used in the treatment of chronic and acute conditions of the skin and subcutaneous tissue; ossatron, used for multiple orthopedic conditions, and orthopace, for orthopedic and musculoskeletal indications....
-
Product Insights
NewCochlear Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Cochlear Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to the customers. It develops, manufactures, and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone anchored prosthetics and wireless accessories including wireless...
-
Product Insights
NewSynDermix AG Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our SynDermix AG Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. SynDermix AG (SynDermix), formerly Pharmagenix AG, is a clinical-stage biotechnology company which develops bio-pharmaceutical products and medical devices for treating rare diseases, chronic wounds and ENT (ears, nose and throat) disorders. Its product portfolio includes SDX-3101 for treating chronic rhinosinusitis, SDX-3103 against migraine, SDX-3104 indicated for chronic wounds. The company's vibration therapies are based on connected medical devices that provide...
-
Sector Analysis
Automotive Vision Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Vision Systems Market Report Overview The automotive vision systems market size was estimated at 709.3 million units in 2023. The market will grow at a CAGR of more than 1% during 2023-2028. Increased consumer awareness regarding road safety and a desire for advanced features are driving the growth of vision system technologies. The Asia-Pacific region had a significant share in the automotive vision systems market. Automotive Vision Systems Market Outlook 2023-2028 (Million Units) Buy the Full Report for Additional...